Skip to main content
. 2015 Feb 24;2015:560404. doi: 10.1155/2015/560404

Table 4.

Effect of SL-A002 extract against L1210 lymphoid leukemia in CDF1 mice.

Treatments Dose (mg/kg) Mean survival time Increase in mean survival time (%) Inference
Normal saline (0.2 mL/mouse) 12
5-FU 20 19 158.33 Significant activity
SL-A002 100 19 158.33 Significant activity

T/C% < 125% = toxic/inactive.

T/C% > 125% = significant antileukemic effect.

n = 6,10 for control.